Ian Fraser
Head of Clinical Operations
Ian brings 30 years of experience in clinical operations across the CRO, large pharma, and biotech sectors. Having initially joined Symbio in April 2024, he was appointed to lead Symbio’s Global Operational Groups, overseeing Monitoring, Project Management, Regulatory Affairs, Medical Affairs, and Site Management.
Ian has held several senior leadership roles, including Chief Operating Officer (COO) – CamOncology, COO & Executive Vice President, Clinical Development – Bionical EMAS and COO & Senior Vice President, Operations Americas & EUME – Clinipace.
His extensive expertise spans leadership, operational delivery, strategic planning, business growth, financial oversight, and quality management. Over his career, he has been involved in numerous therapeutic areas, including oncology, immunology, respiratory, CNS, cardiovascular, dermatology, and ophthalmology.
Ian holds a B.S. (Hons) in Biology & Chemistry from the University of Brighton. His strategic vision and operational excellence make him a key driver of efficiency and innovation within Symbio’s global operations.